STOCK TITAN

MetLife CFO John D. McCallion sells 6,533 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

MetLife Inc. EVP & Chief Financial Officer John D. McCallion exercised options to acquire 6,533 common shares on November 18, 2026, at an exercise price of $46.85 per share, then sold 6,533 shares at a weighted average price of $99.8451 per share in multiple open-market transactions.

Insider McCallion John D.
Role EVP & Chief Financial Officer
Sold 6,533 shs ($652K)
Approx. gross sale proceeds $652K
Approx. exercise cost $306K
Approx. pre-tax spread $346K
Share of Position Sold 2.4%
Type Security Shares Price Value
Exercise Employee Stock Options (right to buy) F2 6,533 $0.00 $0.00
Exercise Common Stock 6,533 $46.85 $306K
Sale Common Stock F1 6,533 $99.8451 $652K
Holdings After Transaction: Employee Stock Options (right to buy) — 0 options (Direct); Common Stock — 269,137 shares (Direct)
Holdings Before and After: Employee Stock Options (right to buy), 6,533 to 0 options (Direct); Common Stock, 269,137 to 269,137 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (2)
  1. F1. The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $99.56 to $100.205, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
  2. F2. The options became exercisable in three substantially equal installments on February 28, 2018, 2019 and 2020.
Options exercised 6,533 options Exercised on November 18, 2026.
Exercise price $46.85 per share Price for the options exercised on November 18, 2026.
Shares sold 6,533 shares Sold on November 18, 2026.
Weighted average sale price $99.8451 per share Weighted average for multiple open-market transactions on November 18, 2026.
Sale price range $99.56–$100.205 per share Prices in the multiple open-market transactions; inclusive.
weighted average price financial
"weighted average price of the aggregate number of shares sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MET shares did John D. McCallion sell, and at what price?

He sold 6,533 shares at a weighted average price of $99.8451 per share on November 18, 2026. The shares were sold in multiple open-market transactions at prices ranging from $99.56 to $100.205 per share, inclusive. No Rule 10b5-1 plan is reported.

At what price did John D. McCallion exercise MET options?

He exercised 6,533 options at $46.85 per share on November 18, 2026, to acquire 6,533 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McCallion John D.

(Last)(First)(Middle)
METLIFE, INC.
200 PARK AVENUE

(Street)
NEW YORK NEW YORK 10166

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/18/2026M6,533A$46.85275,670D
Common Stock11/18/2026S6,533D$99.8451(1)269,137D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Options (right to buy)$46.8511/18/2026M6,533 (2)02/27/2027Common Stock6,533$00D
Explanation of Responses:
1. The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $99.56 to $100.205, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
2. The options became exercisable in three substantially equal installments on February 28, 2018, 2019 and 2020.
Remarks:
/s/ Taylor McInerney Jansen, Attorney-in-fact11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading